ETP derivatives
US-9527868-B2 · Dec 27, 2016 · US
US9856273B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9856273-B2 |
| Application number | US-201615242318-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 19, 2016 |
| Priority date | Oct 22, 2012 |
| Publication date | Jan 2, 2018 |
| Grant date | Jan 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein, inter alia, is the synthesis of ETP derivatives. The uses of the ETP derivatives described herein include treatment of cancer.
Opening claim text (preview).
What is claimed is: 1. A compound having formula: wherein: p is 2; X 1 is CR 21 R 21A , O, NR 21A , or S; X 2 is CR 22 R 22A , O, NR 22A , or S; R 1 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33A , —NR 34A R 35A , —COOR 33A , —CONR 34A R 35A , —NO 2 , —SR 36A , —SO n1 R 34A , —SO n1 OR 34A , —SO n1 NR 34A R 35A , —NHNR 34A R 35A , —ONR 34A R 35A , —NHC(O)NHNR 34A R 35A , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 2 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33B , —NR 34B R 35B , —COOR 33B , —CONR 34B R 35B , —NO 2 , —SR 36B , —SO n2 R 34B , —SO n2 OR 34B , —SO n2 NR 34B R 35B , —NHNR 34B R 35B , —ONR 34B R 35B , —NHC(O)NHNR 34B R 35B , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 3 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33C , —NR 34C R 35C , —COOR 33C , —CONR 34C R 35C , —NO 2 , —SR 36C , —SO n3 R 34C , —SO n3 OR 34C , —SO n3 NR 34C R 35C , —NHNR 34C R 35C , —ONR 34C R 35C , —NHC(O)NHNR 34C R 35C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 4 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33D , —NR 34D R 35D , —COOR 33D , —CONR 34D R 35D , —NO 2 , —SR 36D , —SO n4 R 34D , —SO n4 OR 34D , —SO n4 NR 34D R 35D , —NHNR 34D R 35D , —ONR 34D R 35D , —NHC(O)NHNR 34D R 35D , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 5 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33E , —NR 34E R 35E , —COOR 33E , —CONR 34E R 35E , —NO 2 , —SR 36E , —SO n5 R 34E , —SO n5 OR 34E , —SO n5 NR 34E R 35E , —NHNR 34E R 35E , —ONR 34E R 35E , —NHC(O)NHNR 34E R 35E , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 6 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33F , —NR 34F R 35F , —COOR 33F , —CONR 34F R 35F , —NO 2 , —SR 36F , —SO n6 R 34F , —SO n6 OR 34F , —SO n6 NR 34F R 35F , —NHNR 34F R 35F , —ONR 34F R 35F , —NHC(O)NHNR 34F R 35F , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 7 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33I , —NR 34I R 35I , —COOR 33I , —CONR 34I R 35I , —NO 2 , —SR 36I , —SO n9 R 34I , —SO n9 OR 34I , —SO n9 NR 34I R 35I , —NHNR 34I R 35I , —ONR 34I R 35I , —NHC(O)NHNR 34I R 35I , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 10 and R 11 are independently hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33L , —NR 34L R 35L , —COOR 33L , —CONR 34L R 35L , —NO 2 , —SR 36L , —SO n12 R 34L , —SO n12 OR 34L , —SO n12 NR 34L R 35L , —NHNR 34L R 35L , —ONR 34L R 35L , —NHC(O)NHNR 34L R 35L , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, or are optionally joined together to form a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted heterocycloalkyl, a substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl; R 12 and R 13 are independently hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33M , —NR 34M R 35M , —COOR 33M , —CONR 34M R 35M , —NO 2 , —SR 36M , —SO n13 R 34M , —SO n13 OR 34M , —SO n3 R 34M R 35M , —NHNR 34M R 35M , —ONR 34M R 35M , —NHC(O)NHNR 34M R 35M , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 21 , R 21A , R 22 and R 22A are independently hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, —OR 33M , —NR 34M R 35M , —COOR 33M , —CONR 34M R 35M , —NO 2 , —SR 36M , —SO n13 R 34M , —SO n13 OR 34M , —SO n13 NR 34M R 35M , —NHNR 34M R 35M , —ONR 34M R 35M , —NHC(O)NHNR 34M R 35M , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and R 33A , R 34A , R 35A , R 36A , R 33B , R 34B , R 35B , R 36B , R 33C , R 34C , R 35C , R 36C , R 33D , R 34D , R 35D , R 36D , R 33E , R 34E , R 35E , R 36E , R 33F , R 34F , R 35F , R 36F , R 33I , R 34I , R 35I , R 36I , R 33L , R 34L , R 35L , R 36L , R 33M , R 34M , R 35M , and R 36M are independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n1, n2, n3, n4, n5, n6, n9, n12, and n13 are independently 1 or 2. 2. The compound of claim 1 , having formula: 3. The compound of claim 2 , wherein X 1 and X 2 are independently O or S. 4. The compound of claim 2 , having formula: 5. The compound of claim 1 , wherein R 1 is hydrogen, halogen, —CF 3 , —CN, —CHO, —OR 33A , —NR 34A R 35A , —COOR 33A , —CONR 34A R 35A , —SR 36A , —NHNR 34A R 35A , —ONR 34A R 35A , —NHC(O)NHNR 34A R 35A , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, or substituted or unsubstituted heterocycloalkyl. 6. The compound of claim 5 , wherein R 1 is hydrogen, halogen, —CF 3 , —CN, —OR 33A , —NR 34A R 35A , —COOR 33A , —CONR 34A R 35A , or substituted or unsubstituted alkyl. 7. The compound of claim 6 , wherein: R 1 is hydrogen, —CN, —OR 33A , —NR 34A R 35A , —COOR 33A , —CONR 34A R 35A , or substituted or unsubstituted alkyl, and R 33A , R 34A , and R 35A are independently hydrogen, or substituted or unsubstituted alkyl. 8. The compound of claim 5 , wherein R 2 is hydrogen, halogen, —CF 3 , —CN, —OR 33B , —NR 34B R 35B , —COOR 33B , —CONR 34B R 35B , or substituted or unsubstituted alkyl.
containing six-membered rings with nitrogen as a ring hetero atom · CPC title
Antineoplastic agents · CPC title
Ortho-condensed systems · CPC title
having two or more sulfur atoms in the same ring · CPC title
having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.